| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 211,931 | 262,499 | 231,753 | 262,067 | | Cost of Revenue | 12,854 | 16,068 | 19,561 | 30,179 | | | Gross Profit |
-
| 246,431 | 212,192 | 231,888 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 135,567 | 136,513 | 125,150 | 141,169 | | Non Recurring |
-
|
-
|
-
| 49,633 | | Others | 55,865 | 99,987 | 72,802 | 26,463 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 9,931 | 14,240 | 14,623 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 7,645 | 9,931 | 14,240 | 15,973 | | Interest Expense | 6,224 | 4,232 | 5,033 | 8,685 | | Income Before Tax | 1,421 | 5,699 | 9,207 | 7,288 | | Income Tax Expense | (6,966) | (986) | 1,632 | (1,646) | | Minority Interest | (348) | 88 | (115) | 1,350 | | | | Net Income From Continuing Ops | 8,039 | 6,773 | 7,460 | 8,934 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,039 | 6,773 | 7,460 | 8,934 | | Preferred Stock And Other Adjustments | (5,502) | (5,501) | (5,501) | (2,445) | | | Net Income Applicable To Common Shares | $2,537 | $1,272 | $1,959 | $6,489 |
|
0.31% Nasdaq 
0.05%
Income Statement
